Antisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide
Pharmacology seminar by Annemieke Aartsma-Rus, Leiden University Medical Center, the Netherlands
Hosted by ERN-RND
Tuesday 15:00–16:10 London (GMT+1)
Recording available
ZA Leiden, Netherlands · Hybrid